WO2005005627A3 - Applications d'une nouvelle classe d'enzymes : les sulfiredoxines. - Google Patents

Applications d'une nouvelle classe d'enzymes : les sulfiredoxines. Download PDF

Info

Publication number
WO2005005627A3
WO2005005627A3 PCT/FR2004/001727 FR2004001727W WO2005005627A3 WO 2005005627 A3 WO2005005627 A3 WO 2005005627A3 FR 2004001727 W FR2004001727 W FR 2004001727W WO 2005005627 A3 WO2005005627 A3 WO 2005005627A3
Authority
WO
WIPO (PCT)
Prior art keywords
sulfiredoxines
enzymes
applications
new class
cys
Prior art date
Application number
PCT/FR2004/001727
Other languages
English (en)
Other versions
WO2005005627A2 (fr
Inventor
Michel Toledano
Benoit Biteau
Original Assignee
Commissariat Energie Atomique
Michel Toledano
Benoit Biteau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Michel Toledano, Benoit Biteau filed Critical Commissariat Energie Atomique
Priority to JP2006518281A priority Critical patent/JP2007528207A/ja
Priority to CA002531235A priority patent/CA2531235A1/fr
Priority to US10/563,375 priority patent/US20110189154A1/en
Priority to EP04767567A priority patent/EP1641919A2/fr
Publication of WO2005005627A2 publication Critical patent/WO2005005627A2/fr
Publication of WO2005005627A3 publication Critical patent/WO2005005627A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0051—Oxidoreductases (1.) acting on a sulfur group of donors (1.8)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Applications d'une nouvelle classe d'enzymes, les sulfirédoxines (Srx), qui catalyse la réduction des dérivés Cys-SO2#191H (cystéine-acide sulfinique) et notamment la réduction de la peroxyrédoxine (Prx) sous sa forme Cys-SO 2#191H en dérivé thiol.
PCT/FR2004/001727 2003-07-04 2004-07-02 Applications d'une nouvelle classe d'enzymes : les sulfiredoxines. WO2005005627A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2006518281A JP2007528207A (ja) 2003-07-04 2004-07-02 酵素の新規なクラス：スルフィレドキシンの適用
CA002531235A CA2531235A1 (fr) 2003-07-04 2004-07-02 Applications d'une nouvelle classe d'enzymes : les sulfiredoxines.
US10/563,375 US20110189154A1 (en) 2003-07-04 2004-07-02 Applications For A New Class Of Enzymes: Sulfiredoxins
EP04767567A EP1641919A2 (fr) 2003-07-04 2004-07-02 Applications d une nouvelle classe d' enzymes : les sulf iredoxines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0308212 2003-07-04
FR0308212A FR2857022B1 (fr) 2003-07-04 2003-07-04 Applications d'une nouvelle classe d'enzymes: les sulfiredoxines

Publications (2)

Publication Number Publication Date
WO2005005627A2 WO2005005627A2 (fr) 2005-01-20
WO2005005627A3 true WO2005005627A3 (fr) 2005-12-08

Family

ID=33522782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2004/001727 WO2005005627A2 (fr) 2003-07-04 2004-07-02 Applications d'une nouvelle classe d'enzymes : les sulfiredoxines.

Country Status (6)

Country Link
US (1) US20110189154A1 (fr)
EP (1) EP1641919A2 (fr)
JP (1) JP2007528207A (fr)
CA (1) CA2531235A1 (fr)
FR (1) FR2857022B1 (fr)
WO (1) WO2005005627A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6989428B2 (ja) * 2018-03-23 2022-01-05 アークレイ株式会社 前処理剤、前処理キット、抗原検査キット及び抗原検査方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040695A2 (fr) * 1999-01-08 2000-07-13 Ceres, Inc. Fragments d'adn determines selon leur sequence et polypeptides correspondants codes par lesdits fragments
FR2798672A1 (fr) * 1999-09-17 2001-03-23 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040695A2 (fr) * 1999-01-08 2000-07-13 Ceres, Inc. Fragments d'adn determines selon leur sequence et polypeptides correspondants codes par lesdits fragments
US20020172952A1 (en) * 1999-06-30 2002-11-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
FR2798672A1 (fr) * 1999-09-17 2001-03-23 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BITEAU BENOIT ET AL: "ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin.", NATURE (LONDON), vol. 425, no. 6961, 30 October 2003 (2003-10-30), pages 980 - 984, XP001189048, ISSN: 0028-0836 (ISSN print) *
DATABASE UNIPROT [online] 1 June 1994 (1994-06-01), POHL,T.M, AND POHL, F.M.: "Hypothetical UPF0238 protein YKL086W", XP002273872, Database accession no. YKI6_YEAST *
WOO HYUN AE ET AL: "Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation.", SCIENCE (WASHINGTON D C), vol. 300, no. 5619, 25 April 2003 (2003-04-25), pages 653 - 656, XP002273871, ISSN: 0036-8075 (ISSN print) *

Also Published As

Publication number Publication date
WO2005005627A2 (fr) 2005-01-20
CA2531235A1 (fr) 2005-01-20
US20110189154A1 (en) 2011-08-04
FR2857022A1 (fr) 2005-01-07
JP2007528207A (ja) 2007-10-11
FR2857022B1 (fr) 2007-10-05
EP1641919A2 (fr) 2006-04-05

Similar Documents

Publication Publication Date Title
EP1736465A4 (fr) Dérivés d'aniline
AU2003304093A1 (en) Catalytic preburner and associated methods of operation
AU2003300021A1 (en) Thiosemicarbazones as anti-virals and immunopotentiators
EP1551953B8 (fr) Modulation de la differenciation de cellules souches et progenitrices, analyses et utilisations correspondantes
AU2003252259A1 (en) Novel haloalkylsulfonanilide derivatives, herbicides and usage thereof
WO2005066151A3 (fr) Inhibiteurs d'histone desacetylase
AU2002303933A1 (en) Fluidic valves, agitators, and pumps and methods thereof
AU2003256613A1 (en) Protein conjugates with a water-soluble biocompatible, biogradable polymer
AU2003291307A1 (en) Emissions reduction portfolio
AU2003273249A1 (en) Laminate structures, methods for production thereof and uses therefor
AU2002316939A1 (en) Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
AU2002366879A1 (en) Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility
AU2003273882A1 (en) Self-closing membrane valve
AU2003295726A1 (en) Hemostasis valve and a method of using the hemostasis valve
WO2006029398A8 (fr) Tout-trans-retinol:tout-trans-13,14-dihydroretinol saturase et procedes d'utilisation de cette enzyme
AU2003299344A1 (en) Game mobile element, such as a game piece, and related game system
AU2003287898A1 (en) A mobile terminal with a hinge, a method of operating the mobile terminal and a hinge
AU2003205558A1 (en) Thioibotenic acid and derivatives thereof
AU2003289910A1 (en) Isophtalic acid derivatives
WO2002030970A3 (fr) Regulation de l'histone deacetylase humaine
WO2005005627A3 (fr) Applications d'une nouvelle classe d'enzymes : les sulfiredoxines.
AU2003261327A1 (en) Base assemblies, methods of production and uses thereof
AU2003232244A1 (en) Nanofiller, production, and use
AU2002319560A1 (en) Single jet, single stage cryogenic modulator
AU2003232470A1 (en) Fibre-reactive azo dyes, their production and their use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006518281

Country of ref document: JP

ENP Entry into the national phase

Ref document number: 2531235

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004767567

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004767567

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10563375

Country of ref document: US